联合治疗公司(NASDAQ:UTHR)报告其季度每股收益为6.19美元，低于分析师预期的6.27美元，差距为1.28%。 与去年同期每股收益4.36美元相比，这增加了41.97%。 该公司报告其季度销售额为7.359亿美元，高于分析师预期的7.3474亿美元，增长了0.16%。 与去年同期销售额6.147亿美元相比，这增加了19.72%。
以上内容来自Benzinga Earnings专栏，原文如下：
United Therapeutics (NASDAQ:UTHR) reported quarterly earnings of $6.19 per share which missed the analyst consensus estimate of $6.27 by 1.28 percent. This is a 41.97 percent increase over earnings of $4.36 per share from the same period last year. The company reported quarterly sales of $735.90 million which beat the analyst consensus estimate of $734.74 million by 0.16 percent. This is a 19.72 percent increase over sales of $614.70 million the same period last year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.